| Luciferase expression allows bioluminescence imaging but imposes limitations on the orthotopic mouse (4T1) model of breast cancer VP Baklaushev, A Kilpeläinen, S Petkov, MA Abakumov, NF Grinenko, ... Scientific reports 7 (1), 7715, 2017 | 123 | 2017 |
| Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43 VP Chekhonin, VP Baklaushev, GM Yusubalieva, AE Belorusova, ... Nanomedicine: Nanotechnology, Biology and Medicine 8 (1), 63-70, 2012 | 80 | 2012 |
| COVID-19. Aetiology, pathogenesis, diagnosis and treatment VP Baklaushev, SV Kulemzin, АА Gorchakov, VN Lesnyak, ... Journal of Clinical Practice 11 (1), 7-20, 2020 | 75 | 2020 |
| Treatment of glioma by cisplatin-loaded nanogels conjugated with monoclonal antibodies against Cx43 and BSAT1 VP Baklaushev, NN Nukolova, AS Khalansky, OI Gurina, GM Yusubalieva, ... Drug delivery 22 (3), 276-285, 2015 | 68 | 2015 |
| Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials C Axfors, P Janiaud, AM Schmitt, J van’t Hooft, ER Smith, NA Haber, ... BMC infectious diseases 21, 1-23, 2021 | 61 | 2021 |
| Modeling and immunohistochemical analysis of C6 glioma In Vivo VP Chekhonin, VP Baklaushev, GM Yusubalieva, KA Pavlov, OV Ukhova, ... Bulletin of experimental biology and medicine 143, 501-509, 2007 | 58 | 2007 |
| Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19 M Byazrova, G Yusubalieva, A Spiridonova, G Efimov, D Mazurov, ... Clinical & Translational Immunology 10 (2), e1245, 2021 | 55 | 2021 |
| Visualization of Connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies VP Baklaushev, GM Yusubalieva, EB Tsitrin, OI Gurina, NP Grinenko, ... Drug delivery 18 (5), 331-337, 2011 | 49 | 2011 |
| Treatment of poorly differentiated glioma using a combination of monoclonal antibodies to extracellular connexin-43 fragment, temozolomide, and radiotherapy GM Yusubalieva, VP Baklaushev, OI Gurina, YA Zorkina, IL Gubskii, ... Bulletin of experimental biology and medicine 157, 510-515, 2014 | 41 | 2014 |
| Immunofluorescent analysis of connexin-43 using monoclonal antibodies to its extracellular domain VP Baklaushev, OI Gurina, GM Yusubalieva, NF Grinenko, EB Cytrin, ... Bulletin of experimental biology and medicine 148, 725-730, 2009 | 34 | 2009 |
| Targeted transport of 125I-labeled antibody to GFAP and AMVB1 in an experimental rat model of C6 glioma VP Chekhonin, VP Baklaushev, GM Yusubalieva, OI Gurina Journal of neuroimmune pharmacology 4 (1), 28-34, 2009 | 34 | 2009 |
| Фундаментальные и прикладные аспекты изучения гематоэнцефалического барьера ВП Чехонин, ВП Баклаушев, ГМ Юсубалиева, НЕ Волгина, ОИ Гурина Вестник Российской академии медицинских наук 67 (8), 66-78, 2012 | 30 | 2012 |
| Gene encoding chitinase 3-like 1 protein (CHI3L1) is a putative oncogene VM Kavsan, VP Baklaushev, OV Balynska, AV Iershov, PO Areshkov, ... International journal of biomedical science: IJBS 7 (3), 230, 2011 | 27 | 2011 |
| Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern AA Gorchakov, SV Kulemzin, SV Guselnikov, KO Baranov, ... Cell Discovery 7 (1), 96, 2021 | 26 | 2021 |
| Modeling and integral X-ray, optical, and MRI visualization of multiorgan metastases of orthotopic 4T1 breast carcinoma in BALB/c mice VP Baklaushev, NF Grinenko, GM Yusubalieva, MA Abakumov, IL Gubskii, ... Bulletin of Experimental Biology and Medicine 158, 581-588, 2015 | 25 | 2015 |
| Antitumor effects of monoclonal antibodies to connexin 43 extracellular fragment in induced low-differentiated glioma GM Yusubalieva, VP Baklaushev, OI Gurina, MV Gulyaev, YA Pirogov, ... Bulletin of experimental biology and medicine 153, 163-169, 2012 | 24 | 2012 |
| Low circulating vitamin D in intensive care unit–admitted COVID-19 patients as a predictor of negative outcomes MV Bychinin, TV Klypa, IA Mandel, SA Andreichenko, VP Baklaushev, ... The Journal of Nutrition 151 (8), 2199-2205, 2021 | 22 | 2021 |
| Recent developments in glioblastoma therapy: oncolytic viruses and emerging future strategies A Hamad, GM Yusubalieva, VP Baklaushev, PM Chumakov, AV Lipatova Viruses 15 (2), 547, 2023 | 21 | 2023 |
| Connexin 43‐targeted T1 contrast agent for MRI diagnosis of glioma T Abakumova, M Abakumov, S Shein, P Chelushkin, D Bychkov, ... Contrast media & molecular imaging 11 (1), 15-23, 2016 | 20 | 2016 |
| Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6 NV Nukolova, VP Baklaushev, TO Abakumova, PA Mel’nikov, ... Bulletin of experimental biology and medicine 157, 524-529, 2014 | 19 | 2014 |
Vladimir BaklaushevFederal Center of Brain Research and Neurotechnologies FMBA of Russia確認したメール アドレス: fccps.ru
